Latest news
THE LUSTGARTEN FOUNDATION AND BREAK THROUGH CANCER ANNOUNCE NEW CLINICAL TRIAL EVALUATING KRAS-TARGETED IMMUNOTHERAPY STRATEGY FOR PANCREATIC CANCER - PR NewswirePR Newswire · Mon, 10 Aug 2026 13:50:00 GMTAmplia Therapeutics (ASX:ATX) Firms As Market Watches Pancreatic Cancer Program - KalkineKalkine · Mon, 10 Aug 2026 13:39:00 GMTNew drug delivers promising survival gains in pancreatic cancer - news-medical.netnews-medical.net · Mon, 10 Aug 2026 03:11:00 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago TribuneChicago Tribune · Sun, 09 Aug 2026 11:00:17 GMT'We're excited and ready to go': Fast-growing Revolution Medicines preps potential launch of blockbuster pancreatic cancer drug - The Business JournalsThe Business Journals · Fri, 07 Aug 2026 13:29:00 GMTExperimental Pancreatic Cancer Vaccine Triggered Targeted Immune Responses in 18 of 20 High-Risk Patients - Medical DailyMedical Daily · Fri, 07 Aug 2026 12:30:03 GMTNew study explores cholesterol-driven survival mechanisms in pancreatic cancer - news-medical.netnews-medical.net · Fri, 07 Aug 2026 01:49:00 GMT$2 Million NCI Grant Funds Research on How Pancreatic Cancer Uses Cholesterol to Survive - The University of OklahomaThe University of Oklahoma · Thu, 06 Aug 2026 20:46:15 GMT